Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 1453-1464 of 22347

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’

AM Best Affirms Credit Ratings of Qatar Islamic Insurance Group Q.P.S.C.

LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit

Left to right are David Sole (School for CEOs) and Fiona James-Martin (Carlyle)

Executive Leadership and Search Specialist Carlyle Acquires Majority Stake in David Sole-run School for CEOs

B2C2 and Solidus Labs Partner to Bolster Institutional-Grade Crypto-Native Market Integrity

Expensify and VAT IT Launch Integration Partnership to Simplify Global VAT Reclaim

Everest Establishes Joseph V. Taranto Scholarship to Advance Commitment to Developing Future Leaders

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data.

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy

The Live Moment Effect report from Genius Sports and MediaScience.

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall

Acuity Analytics Launches Domain-Led Agentic AI Platform to Help Financial Institutions Move from Experimentation to Enterprise Value

Alkermes Showcases Data From Psychiatry Portfolio and Sleep Research into Real World Patient Experience at Spring 2026 Scientific Conferences

Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis